Clinical trial

Combination Chemotherapy With or Without Bone Marrow or Stem Cell…

NCT00002596 · Memorial Sloan Kettering Cancer Center, Other · Completed

Key facts

NCT number NCT00002596
Title Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
Official title RANDOMIZED MULTIINSTITUTIONAL PHASE III TRIAL OF BEP AND HIGH DOSE CHEMOTHERAPY VERSUS BEP ALONE IN PREVIOUSLY UNTREATED PATIENTS WITH POOR RISK GERM CELL TUMORS
Lead sponsor Memorial Sloan Kettering Cancer Center, Other
Collaborators National Cancer Institute (NCI) NIH Eastern Cooperative Oncology Group SWOG Cancer Research Network Cancer and Leukemia Group B
Status Completed
Phase Phase 3
Study type Interventional
Conditions Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
Intervention type Biological, Drug, Procedure, Radiation
Interventions bleomycin sulfate, filgrastim, carboplatin, cisplatin, cyclophosphamide, etoposide, autologous bone marrow transplantation, bone marrow ablation with stem cell support, conventional surgery, peripheral blood stem cell transplantation and 1 more
Enrollment 270
Start date Sep 1, 1994
Completion Jul 1, 2006
First posted Jan 27, 2003
Last update posted Jun 26, 2013
Countries Australia, Peru, Puerto Rico, United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies